Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway

2015 ◽  
Vol 50 (10) ◽  
pp. 1027-1040 ◽  
Author(s):  
Xiaoying Zhou ◽  
Wei Liu ◽  
Min Gu ◽  
Hongwen Zhou ◽  
Guoxin Zhang
Helicobacter ◽  
2011 ◽  
Vol 16 (2) ◽  
pp. 79-88 ◽  
Author(s):  
Stergios A. Polyzos ◽  
Jannis Kountouras ◽  
Christos Zavos ◽  
Georgia Deretzi

Helicobacter ◽  
2009 ◽  
Vol 14 (5) ◽  
pp. 496-502 ◽  
Author(s):  
Toshiaki Gunji ◽  
Nobuyuki Matsuhashi ◽  
Hajime Sato ◽  
Kazutoshi Fujibayashi ◽  
Mitsue Okumura ◽  
...  

2007 ◽  
Vol 30 (3) ◽  
pp. 236-240 ◽  
Author(s):  
S. Ozdem ◽  
M. Akcam ◽  
A. Yilmaz ◽  
R. Artan

2014 ◽  
Vol 306 (2) ◽  
pp. E197-E209 ◽  
Author(s):  
Hongliang Li ◽  
Jiyeon Lee ◽  
Chaoyong He ◽  
Ming-Hui Zou ◽  
Zhonglin Xie

Nutrient overload is associated with the development of obesity, insulin resistance, and type 2 diabetes. However, the underlying mechanisms for developing insulin resistance in the presence of excess nutrients are incompletely understood. We investigated whether activation of AMP-activated protein kinase (AMPK) prevents the hepatic insulin resistance that is induced by the consumption of a high-protein diet (HPD) and the presence of excess amino acids. Exposure of HepG2 cells to excess amino acids reduced AMPK phosphorylation, upregulated Notch1 expression, and impaired the insulin-stimulated phosphorylation of Akt Ser473 and insulin receptor substrate-1 (IRS-1) Tyr612. Inhibition of Notch1 prevented amino acid-induced insulin resistance, which was accompanied by reduced expression of Rbp-Jk, hairy and enhancer of split-1, and forkhead box O1. Mechanistically, mTORC1 signaling was activated by excess amino acids, which then positively regulated Notch1 expression through the activation of the signal transducer and activator of transcription 3 (STAT3). Activation of AMPK by metformin inhibited mTORC1-STAT3 signaling, thereby preventing excess amino acid-impaired insulin signaling. Finally, HPD feeding suppressed AMPK activity, activated mTORC1/STAT3/Notch1 signaling, and induced insulin resistance. Chronic administration of either metformin or rapamycin inhibited the HPD-activated mTORC1/STAT3/Notch1 signaling pathway and prevented hepatic insulin resistance. We conclude that the upregulation of Notch1 expression by hyperactive mTORC1 signaling is an essential event in the development of hepatic insulin resistance in the presence of excess amino acids. Activation of AMPK prevents amino acid-induced insulin resistance through the suppression of the mTORC1/STAT3/Notch1 signaling pathway.


2008 ◽  
Vol 54 (9) ◽  
pp. 1966-1970 ◽  
Author(s):  
Ahad Eshraghian ◽  
Seyed Ali Hashemi ◽  
Alireza Hamidian Jahromi ◽  
Hamed Eshraghian ◽  
Seyed Masoum Masoompour ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Xinyu Cao ◽  
Xiaotong Ye ◽  
Shuang Zhang ◽  
Li Wang ◽  
Yanhong Xu ◽  
...  

Extracellular ADP, a derivative of ATP, interacts with the purinergic receptors in the cell membrane to regulate cellular activities. This signaling pathway remains unknown in the regulation of blood glucose in vivo. We investigated the acute activity of ADP in mice through a peritoneal injection. In the lean mice, in response to the ADP treatment, the blood glucose was elevated, and pyruvate tolerance was impaired. Hepatic gluconeogenesis was enhanced with elevated expression of glucogenic genes (G6pase and Pck1) in the liver. An elevation was observed in NADH, cAMP, AMP, GMP and citrate in the liver tissue in the targeted metabolomics assay. In the primary hepatocytes, ADP activated the cAMP/PKA/CREB signaling pathway, which was blocked by the antagonist (2211) of the ADP receptor P2Y13. In the circulation, gluconeogenic hormones including glucagon and corticosterone were elevated by ADP. Insulin and thyroid hormones (T3 and T4) were not altered in the blood. In the diet-induced obese (DIO) mice, NADH was elevated in the liver tissue to match the hepatic insulin resistance. Insulin resistance was intensified by ADP for further impairment in insulin tolerance. These data suggest that ADP induced the blood glucose through direct and indirect actions in liver. One of the potential pathways involves activation of the P2Y13/cAMP/PKA/CREB signaling pathway in hepatocytes and the indirect pathway may involve induction of the gluconeogenic hormones. NADH is a signal for gluconeogenesis in the liver of both DIO mice and lean mice.


Sign in / Sign up

Export Citation Format

Share Document